The House and Senate are working on legislation to halt the opioid abuse epidemic.
“Both the House and the Senate appear motivated to get a comprehensive bill on President Trump’s desk this year,” Bloomberg Intelligence analyst Brian Rye told me recently.
In the House, the Energy and Commerce Committee is working on a legislative package to combat the epidemic with the goal of getting it to the House floor by Memorial Day, Rep. Greg Walden (R-Ore.), chairman of the committee, said March 1 at a forum on opioids.
Walden said his committee will hold two hearings, one in March, to examine bills that would improve the safe disposal of unused medications, give doctors more information about the addiction history of their patients, and establish a database to compile information on federal efforts to stop the opioid crisis.
“The crisis that is ravaging our nation has continued to grow,” and “our efforts simply must grow to meet this challenge,” Walden said. Opioids, including prescription opioids, heroin, and fentanyl, killed more than 42,000 people in 2016, more than any year on record, according to the Centers for Disease Control and Prevention. Walden said his committee has been developing bipartisan legislation for months and combating the opioid crisis is his top priority.
Walden’s committee also held a hearing Feb. 28 on other opioid legislation. At that hearing, committee members appeared split along party lines over how to address the opioid crisis, which indicates trouble for the legislative package. The lawmakers discussed legislation to greatly expand the attorney general’s authority to ban potential dangerous new drugs such as synthetic opioids and to encourage doctors and pharmacists to get more education on opioid prescribing and phone prescriptions.
And in the Senate, the Health, Education, Labor, and Pensions (HELP) Committee is planning to markup opioid legislation before the end of March, Sen. Lamar Alexander (R-Tenn.), chairman of the committee, said at a recent hearing. Specifics on what legislation will be considered haven’t yet been released.
The Senate HELP Committee has held five hearings to examine the epidemic. It also will hold a sixth hearing March 8 to hear from state governors on their efforts and how the federal government can help them.
Read my full article here.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)